HK1042253A1 - 化合物及其用於治療糖尿病並發症的用途 - Google Patents

化合物及其用於治療糖尿病並發症的用途

Info

Publication number
HK1042253A1
HK1042253A1 HK02104296.1A HK02104296A HK1042253A1 HK 1042253 A1 HK1042253 A1 HK 1042253A1 HK 02104296 A HK02104296 A HK 02104296A HK 1042253 A1 HK1042253 A1 HK 1042253A1
Authority
HK
Hong Kong
Prior art keywords
compounds
therapeutic use
diabetic complications
diabetic
complications
Prior art date
Application number
HK02104296.1A
Other languages
English (en)
Inventor
R Brown Truman
Original Assignee
福克斯契思癌症中心
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 福克斯契思癌症中心 filed Critical 福克斯契思癌症中心
Publication of HK1042253A1 publication Critical patent/HK1042253A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK02104296.1A 1998-10-28 2002-06-06 化合物及其用於治療糖尿病並發症的用途 HK1042253A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18211498A 1998-10-28 1998-10-28
PCT/US1999/025358 WO2000024405A1 (en) 1998-10-28 1999-10-28 Compounds and their therapeutic use with diabetic complications

Publications (1)

Publication Number Publication Date
HK1042253A1 true HK1042253A1 (zh) 2002-08-09

Family

ID=22667112

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02104296.1A HK1042253A1 (zh) 1998-10-28 2002-06-06 化合物及其用於治療糖尿病並發症的用途

Country Status (7)

Country Link
EP (1) EP1126856A4 (zh)
JP (1) JP2002528419A (zh)
CN (1) CN1331599A (zh)
AU (1) AU773401C (zh)
CA (1) CA2348844A1 (zh)
HK (1) HK1042253A1 (zh)
WO (1) WO2000024405A1 (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111638363A (zh) * 2020-04-30 2020-09-08 吉林省格瑞斯特生物技术有限公司 3-脱氧果糖快速定量荧光检测装置及其制备方法

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69911771D1 (de) * 1998-06-11 2003-11-06 Fox Chase Cancer Ct Philadelph Methoden zur ermittlung des risikos eines diabetikers für einen mit diabetes in zusammenhang stehenden pathologischen zustand
CA2369755A1 (en) * 1999-04-15 2000-10-26 Fox Chase Cancer Center Method for reducing a susceptibility to tumor formation induced by 3-deoxyglucosone and precursors thereof
US7622117B2 (en) 2002-04-17 2009-11-24 Dynamis Therapeutics, Inc. 3-deoxyglucosone and skin
EP3378472A1 (en) * 2012-08-09 2018-09-26 Dynamis Therapeutics, Inc. Combinations of meglumine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484735A (en) * 1989-08-23 1996-01-16 Northwestern University Immunoassay of glycosylated proteins employing antibody directed to reductively glycosylated N-terminal amino acids
ATE143673T1 (de) * 1989-08-23 1996-10-15 Univ Northwestern Testverfahren von glykosylierten proteinen unter verwendung eines antikörpers gerichtet gegen reduzierte glykosylierte n-terminal-aminosäuren
WO1993004690A1 (en) * 1991-09-09 1993-03-18 Peptide Technology Limited Method for the treatment of the complications and pathology of diabetes
JPH0733667A (ja) * 1992-07-03 1995-02-03 Japan Tobacco Inc ４，６−ｏ−ヒドロキシホスホリルグルコサミン誘導体の水溶液及び水溶化方法
US6228858B1 (en) * 1995-09-12 2001-05-08 University Of Kansas Medical Center Advanced glycation end-product intermediaries and post-amadori inhibition
US5744451A (en) * 1995-09-12 1998-04-28 Warner-Lambert Company N-substituted glutamic acid derivatives with interleukin-1 β converting enzyme inhibitory activity
US6004958A (en) * 1997-02-05 1999-12-21 Fox Chase Cancer Center Compounds and methods for therapeutic intervention in preventing diabetic complications and procedures for assessing a diabetic's risk of developing complications and determining the efficacy of therapeutic intervention
WO1998043649A2 (en) * 1997-03-28 1998-10-08 Otsuka Pharmaceutical Co., Ltd. Age production inhibitory composition comprising a maillard reaction inhibitor and vitamin b¿6?

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111638363A (zh) * 2020-04-30 2020-09-08 吉林省格瑞斯特生物技术有限公司 3-脱氧果糖快速定量荧光检测装置及其制备方法

Also Published As

Publication number Publication date
CA2348844A1 (en) 2000-05-04
WO2000024405A1 (en) 2000-05-04
JP2002528419A (ja) 2002-09-03
EP1126856A1 (en) 2001-08-29
CN1331599A (zh) 2002-01-16
AU773401B2 (en) 2004-05-27
WO2000024405A9 (en) 2000-10-19
AU1709400A (en) 2000-05-15
AU773401C (en) 2005-04-28
EP1126856A4 (en) 2008-05-14

Similar Documents

Publication Publication Date Title
AU2655599A (en) Endoluminal implant with therapeutic and diagnostic capability
AU5372198A (en) Absorbent articles having cuffs with skin care composition disposed thereon
IL131229A0 (en) Compounds and methods for therapeutic intervention in preventing diabetic complications
EG21712A (en) Treatment of insulin resistance
AU2746599A (en) Medical material and medical supply
GB9802599D0 (en) Medical use
IL142778A0 (en) Therapeutic product and its use
HK1042253A1 (zh) 化合物及其用於治療糖尿病並發症的用途
AU2529799A (en) Benzofuran-4-carboxamides and their therapeutic use
GB9824160D0 (en) Heterocyclic compounds and their therapeutic use
GB9816897D0 (en) Therapeutic use
GB9812662D0 (en) Therapeutic use
GB9810920D0 (en) Therapeutic use
EP1112250A4 (en) THERAPEUTIC COMPOUNDS AND RELATED METHODS
GB9811624D0 (en) Therapeutic use
GB9821179D0 (en) Therapeutic use
GB9802622D0 (en) Compounds and their therapeutic use
GB9812664D0 (en) Therapeutic use
GB9704350D0 (en) Compounds and their therapeutic use
GB9823942D0 (en) Therapeutic antibody composition and use
GB9823931D0 (en) Therapeutic antibody composition and use
GB9823934D0 (en) Therapeutic antibody composition and use
GB9823936D0 (en) Therapeutic antibody composition and use
GB9823937D0 (en) Therapeutic antibody composition and use
GB9823939D0 (en) Therapeutic antibody composition and use